checkAd
    Startseite > Aktien > Voyager Therapeutics > Nachrichten
    Voyager Therapeutics Aktie
    7,8750
     
    EUR
    +0,57 %
    +0,0450 EUR
    Letzter Kurs 13.05.24 Tradegate
    7,7400
     
    EUR
    1.300 STK
    Geldkurs 16:31:50
    7,8900
     
    EUR
    1.270 STK
    Briefkurs 16:31:50
    ISIN: US92915B1061 · WKN: A143XJ · SYM: VT6 · USA

    Neueste Nachrichten

    Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
    13.05.24 · globenewswire · Voyager Therapeutics
    Voyager Therapeutics Presents Data for Second-Generation, TRACER-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
    08.05.24 · globenewswire · Voyager Therapeutics
    Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast
    06.05.24 · globenewswire · Voyager Therapeutics
    Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
    22.04.24 · globenewswire · Voyager Therapeutics
    Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
    16.04.24 · globenewswire · Voyager Therapeutics
    Fokus Aktien mit extremen Handelsvolumen am Montag, den 15.04.2024
    15.04.24 · wO Chartvergleich · JH KT
    Fokus Aktien mit extremen Handelsvolumen am Dienstag, den 02.04.2024
    02.04.24 · wO Chartvergleich · Brinker International
    Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    26.03.24 · globenewswire · Voyager Therapeutics
    Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
    13.03.24 · globenewswire · Voyager Therapeutics
    Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
    28.02.24 · globenewswire · Voyager Therapeutics
    Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
    26.02.24 · globenewswire · Voyager Therapeutics
    Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast
    21.02.24 · globenewswire · Voyager Therapeutics